Orbimed Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $16.8 Million - $81.1 Million	-2,183,143 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $29.5 Million - $41.4 Million	-1,114,158 Reduced 33.79%	2,183,143 $74.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $62.7 Million - $91.9 Million	1,916,401 Added 138.78%	3,297,301 $121 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $10.3 Million - $14.5 Million	255,200 Added 22.67%	1,380,900 $61.9 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $1.18 Million - $2.07 Million	-31,900 Reduced 2.76%	1,125,700 $67.2 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $12 Million - $24.7 Million	-356,571 Reduced 23.55%	1,157,600 $47.7 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $30 Million - $66.2 Million	-946,400 Reduced 38.46%	1,514,171 $94.2 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $23.1 Million - $45 Million	-1,157,600 Reduced 31.99%	2,460,571 $83.5 Million
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $24.3 Million - $34.7 Million	1,175,971 Added 48.15%	3,618,171 $84 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $9.32 Million - $17.7 Million	488,700 Added 25.02%	2,442,200 $51.3 Million
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $1.75 Million - $2.2 Million	-52,200 Reduced 2.6%	1,953,500 $75.6 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $9.48 Million - $21.3 Million	472,800 Added 30.84%	2,005,700 $78.9 Million
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $7.15 Million - $10.6 Million	356,830 Added 30.34%	1,532,900 $30.7 Million
Q4 2017 Feb 14, 2018	BUY	$16.54 - $24.2 $12.9 Million - $18.9 Million	781,800 Added 198.29%	1,176,070 $26.7 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $6.96 Million - $7.49 Million	394,270	394,270 $7.49 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account